Literature DB >> 19489711

Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan.

Sheng-Yuan Ruan1, Jung-Yien Chien, Po-Ren Hsueh.   

Abstract

BACKGROUND: During the past 2 decades, invasive trichosporonosis has emerged as an opportunistic infectious disease in immunocompromised patients. However, no case series have been reported recently.
METHODS: All patients with a culture that was positive for Trichosporon species from May 2000 through May 2008 at a medical center were evaluated. The identity of all Trichosporon species was confirmed by analysis of the intergenic spacer 1 region of the fungal ribosomal RNA gene. In vitro susceptibility testing was performed using the reference broth microdilution method.
RESULTS: Forty-three patients were found to have a culture that was positive for Trichosporon species. T. asahii was the most frequently isolated species (32 isolates; 74%), followed by T. dermatis (5; 12%), T. montevideense (2; 5%), and T. asteroides (1; 2%), T. cutaneum (1; 2%), T. faecale (1; 2%), and T. ovoides (1; 2%). Nineteen patients had invasive infections; 16 (84%) were caused by T. asahii, and 1 (5%) each was caused by T. dermatis, T. montevideense, and T. asteroides. Of the 19 episodes of invasive trichosporonosis, 14 (74%) were fungemia, 3 (16%) were pulmonary infection, and 1 (5%) each was soft-tissue infection and meningitis. Most invasive infections were associated with prior antibiotic therapy (95%), use of a central catheter (90%), malignancy (58%), and intensive care unit admission (47%). Azoles had good in vitro activity, whereas amphotericin B and echinocandins were not active against Trichosporon isolates. The 30-day all-cause mortality rate was 42% and was higher among patients with a malignancy (55%) than among those without an underlying malignancy (25%).
CONCLUSIONS: Invasive trichosporonosis tended to develop in patients with an underlying malignancy and to be associated with higher mortality. T. asahii and other unusual Trichosporon species may cause invasive trichosporonosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19489711     DOI: 10.1086/599614

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  38 in total

1.  Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.

Authors:  Moan Shane Tsai; Yun Liang Yang; An Huei Wang; Lih Shinn Wang; Daniel C T Lu; Ci Hong Liou; Li Yun Hsieh; Chi Jung Wu; Ming Fang Cheng; Zhi Yuan Shi; Hsiu Jung Lo
Journal:  Mycopathologia       Date:  2012-02-09       Impact factor: 2.574

2.  In Vitro Activity of Berberine Alone and in Combination with Antifungal Drugs Against Planktonic Forms and Biofilms of Trichosporon Asahii.

Authors:  Lin Cong; Yong Liao; Suteng Yang; Rongya Yang
Journal:  Mycopathologia       Date:  2017-01-31       Impact factor: 2.574

3.  Experimental pathogenicity of a clinical isolate of Trichosporon dermatis in a murine model.

Authors:  Ying-Ping Lin; Yan-Ping Yang; Wen-Ming Huang; Yong-Hua Chen; Shun-Fan Li; Yi-Ming Fan
Journal:  Mycopathologia       Date:  2011-07-13       Impact factor: 2.574

4.  The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.

Authors:  Marçal Mariné; Vinicius Leite Pedro Bom; Patricia Alves de Castro; Lizziane Kretli Winkelstroter; Leandra Naira Ramalho; Neil Andrew Brown; Gustavo Henrique Goldman
Journal:  Virulence       Date:  2015-03-09       Impact factor: 5.882

5.  Answer to November 2020 Photo Quiz.

Authors:  Abdulaziz M Almulhim; Cristina Marie Vellozzi-Averhoff; Jessica Howard-Anderson; Ahmed Babiker; Colleen S Kraft
Journal:  J Clin Microbiol       Date:  2020-10-21       Impact factor: 5.948

6.  Invasive Infections Due to Trichosporon: Species Distribution, Genotyping, and Antifungal Susceptibilities from a Multicenter Study in China.

Authors:  Li-Na Guo; Shu-Ying Yu; Po-Ren Hsueh; Abdullah M S Al-Hatmi; Jacques F Meis; Ferry Hagen; Meng Xiao; He Wang; Cinzia Barresi; Meng-Lan Zhou; G Sybren de Hoog; Ying-Chun Xu
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

7.  Correlation of Trichosporon asahii Genotypes with Anatomical Sites and Antifungal Susceptibility Profiles: Data Analyses from 284 Isolates Collected in the Last 22 Years across 24 Medical Centers.

Authors:  Elaine Cristina Francisco; João N de Almeida Junior; Flávio Queiroz-Telles; Valério Rodrigues Aquino; Ana Verena A Mendes; Marcio de Oliveira Silva; Paulo de Tarso O E Castro; Thais Guimarães; Vinicius Ponzio; Rosane C Hahn; Guilherme M Chaves; Arnaldo L Colombo
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

8.  Emerging Trichosporon asahii in elderly patients: epidemiological and molecular analysis by the DiversiLab system.

Authors:  M Treviño; C García-Riestra; P Areses; X García; D Navarro; F J Suárez; I A López-Dequidt; O Zaragoza; M Cuenca-Estrella
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-10       Impact factor: 3.267

9.  Three-locus identification, genotyping, and antifungal susceptibilities of medically important Trichosporon species from China.

Authors:  Li-Na Guo; Meng Xiao; Fanrong Kong; Sharon C-A Chen; He Wang; Tania C Sorrell; Wei Jiang; Hong-Tao Dou; Ruo-Yu Li; Ying-Chun Xu
Journal:  J Clin Microbiol       Date:  2011-09-07       Impact factor: 5.948

Review 10.  Subcutaneous Infection Associated with Trichosporon ovoides: A Case Report and Review of Literature.

Authors:  Ratna Mohd Tap; Parameswari Sabaratnam; Nur Yasmin Ramli; Rohaidah Hashim; Abd Razak Mohd Fuat; Pey Peng Ng; Husna Khairam; Norazah Ahmad
Journal:  Mycopathologia       Date:  2015-10-22       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.